Walter M. Kirkendall

2.7k total citations · 1 hit paper
76 papers, 2.1k citations indexed

About

Walter M. Kirkendall is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Walter M. Kirkendall has authored 76 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 11 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Molecular Biology. Recurrent topics in Walter M. Kirkendall's work include Blood Pressure and Hypertension Studies (20 papers), Hormonal Regulation and Hypertension (11 papers) and Renin-Angiotensin System Studies (8 papers). Walter M. Kirkendall is often cited by papers focused on Blood Pressure and Hypertension Studies (20 papers), Hormonal Regulation and Hypertension (11 papers) and Renin-Angiotensin System Studies (8 papers). Walter M. Kirkendall collaborates with scholars based in United States, Australia and Democratic Republic of the Congo. Walter M. Kirkendall's co-authors include Edward D. Freis, Frederick H. Epstein, Alan C. Burton, Jeremy Hammond, Merrill Overturf, Annette Fitz, Jay H. Stein, Jonathan K. Wilkin, Manning Feinleib and William R. Wilson and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Walter M. Kirkendall

74 papers receiving 1.8k citations

Hit Papers

Recommendations for Human Blood Pressure Determination by... 1967 2026 1986 2006 1967 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walter M. Kirkendall United States 23 886 376 371 275 236 76 2.1k
Frank A. Finnerty United States 27 817 0.9× 341 0.9× 247 0.7× 313 1.1× 149 0.6× 110 2.2k
Andrew J. Zweifler United States 22 879 1.0× 281 0.7× 308 0.8× 137 0.5× 200 0.8× 61 1.7k
Gordon S. Stokes Australia 26 805 0.9× 237 0.6× 422 1.1× 248 0.9× 283 1.2× 130 2.0k
C J Bulpitt United Kingdom 29 979 1.1× 207 0.6× 475 1.3× 181 0.7× 207 0.9× 97 2.8k
Marvin Moser United States 27 1.3k 1.5× 369 1.0× 555 1.5× 182 0.7× 123 0.5× 154 2.3k
R. Fagard Belgium 27 1.6k 1.8× 310 0.8× 538 1.5× 432 1.6× 312 1.3× 85 2.6k
Mohinder P. Sambhi United States 25 922 1.0× 206 0.5× 751 2.0× 224 0.8× 179 0.8× 98 2.2k
E. B. Raftery United Kingdom 30 1.9k 2.2× 656 1.7× 275 0.7× 311 1.1× 171 0.7× 140 2.9k
R Sannerstedt Sweden 24 893 1.0× 224 0.6× 493 1.3× 112 0.4× 387 1.6× 66 2.0k
T. Strasser Switzerland 10 701 0.8× 463 1.2× 498 1.3× 359 1.3× 126 0.5× 25 2.1k

Countries citing papers authored by Walter M. Kirkendall

Since Specialization
Citations

This map shows the geographic impact of Walter M. Kirkendall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter M. Kirkendall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter M. Kirkendall more than expected).

Fields of papers citing papers by Walter M. Kirkendall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter M. Kirkendall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter M. Kirkendall. The network helps show where Walter M. Kirkendall may publish in the future.

Co-authorship network of co-authors of Walter M. Kirkendall

This figure shows the co-authorship network connecting the top 25 collaborators of Walter M. Kirkendall. A scholar is included among the top collaborators of Walter M. Kirkendall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter M. Kirkendall. Walter M. Kirkendall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holtzman, Jordan L., et al.. (1990). Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients. Clinical Pharmacology & Therapeutics. 48(5). 590–597. 4 indexed citations
3.
Samuel, Paul, et al.. (1988). Effects of isradipine, a new calcium antagonist, versus hydrochlorothiazide on serum lipids and apolipoproteins in patients with systemic hypertension. The American Journal of Cardiology. 62(16). 1068–1071. 9 indexed citations
4.
Tuck, Michael L., et al.. (1986). Low‐Dose Captopril in Mild to Moderate Geriatric Hypertension. Journal of the American Geriatrics Society. 34(10). 693–696. 28 indexed citations
5.
Frishman, William H., Walter M. Kirkendall, John Lunn, et al.. (1985). Diuretics versus calcium-channel blockers in systemic hypertension: A preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem. The American Journal of Cardiology. 56(16). H92–H96. 8 indexed citations
6.
Glassock, Richard J., Richard E. Weitzman, Cathy Bennett, et al.. (1982). Pindolol: Effects on blood pressure and plasma renin activity. American Heart Journal. 104(2). 421–425. 7 indexed citations
7.
Overturf, Merrill, et al.. (1979). Evidence against acetone-soluble renin inhibitors in normal human plasma.. Hypertension. 1(2). 98–105. 5 indexed citations
8.
Hammond, Jeremy, Walter M. Kirkendall, & Richard V. Calfee. (1979). Hypertensive crisis managed by computer controlled infusion of sodium nitroprusside: A model for the closed loop administration of short acting vasoactive agents. Computers and Biomedical Research. 12(2). 97–108. 36 indexed citations
9.
Overturf, Merrill, et al.. (1979). Phthalate esters in normal and pathological human kidneys. Bulletin of Environmental Contamination and Toxicology. 22(1). 536–542. 25 indexed citations
10.
Kirkendall, Walter M., et al.. (1978). RENIN AS A PREDICTOR OF HYPERTENSIVE COMPLICATIONS*. Annals of the New York Academy of Sciences. 304(1). 147–160. 8 indexed citations
11.
Wilson, Curtis B. & Walter M. Kirkendall. (1970). THE EFFECTS OF MEFRUSIDE IN THE WATER DIURETIC AND HYDROPENIC DOG: A COMPARISON WITH CHLOROTHIAZIDE. Journal of Pharmacology and Experimental Therapeutics. 173(2). 422–429. 1 indexed citations
12.
Kirkendall, Walter M. & Jay H. Stein. (1968). Clinical pharmacology furosemide and ethacrynic acid. The American Journal of Cardiology. 22(2). 162–167. 41 indexed citations
13.
Kirkendall, Walter M.. (1967). The Placebo and Clinical Investigation. PubMed. 7(5). 245–247. 5 indexed citations
14.
Fitz, Annette, et al.. (1966). Cardiorenal hemodynamic effects of ethacrynic acid. American Heart Journal. 71(2). 153–165. 21 indexed citations
15.
Kirkendall, Walter M.. (1961). Essential Hypertension: An International Symposium. Archives of Internal Medicine. 108(6). 974–974. 24 indexed citations
16.
Kirkendall, Walter M.. (1960). CURRENT CONCEPTS OF THE MECHANISMS OF HYPERTENSION. Annals of the New York Academy of Sciences. 88(4). 922–926. 1 indexed citations
17.
Kirkendall, Walter M.. (1959). Clinical Evaluation of Chlorothiazide. Circulation. 19(6). 933–941. 9 indexed citations
18.
Kirkendall, Walter M.. (1958). Urine and Urinary Sediment, a Practical Manual and Atlas.. Archives of Internal Medicine. 101(6). 1180–1180. 5 indexed citations
19.
Culbertson, James W., John W. Eckstein, Walter M. Kirkendall, & George N. Bedell. (1957). General Hemodynamics and Splanchnic Circulation in Patients with Coarctation of the Aorta1. Journal of Clinical Investigation. 36(11). 1537–1545. 14 indexed citations
20.
Kirkendall, Walter M.. (1956). The Treatment of Renal Failure.. Archives of Internal Medicine. 98(1). 121–121. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026